A new year in autoimmunity

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 239-242

  Selmi, Carlo ^a,b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

AIRE; Th17; Tolerance

Indexed keywords

AUTOANTIBODY;

AUTOIMMUNITY; B LYMPHOCYTE; CELL ACTIVATION; CLINICAL RESEARCH; CONFERENCE PAPER; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; PATHOGENESIS; REGULATORY T LYMPHOCYTE; SCIENTIFIC LITERATURE; T LYMPHOCYTE; TH17 CELL;

EID: 69949150181     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04878.x     Document Type: Conference Paper

References (48)

1. Shoenfeld Y. et al. 2008. The autoimmunologist: geoepidemiology a new center of gravity, and prime time for autoimmunity. J. Autoimmun. 31: 325-330.
2. Gardner, J.M. et al. 2008. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 321: 843-847.
3. Allina, J. et al. 2008. Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. J. Autoimmun. 30: 238-245.
4. Bazzani, C. et al. 2009. Anti-TNFα therapy in a cohort of rheumatoid arthritis patients: clinical outcomes. Autoimmun. Rev. 8: 260-265.
5. Boscolo, P. et al. 2008. Environmental and occupational stress and autoimmunity. Autoimmun. Rev. 7: 340-343.
6. Dalloul, A. 2008. CD5: A safeguard against autoim-munity and a shield for cancer cells. Autoimmun. Rev.
7. Dimitrov, J.D. et al. 2008. Functional variability of antibodies upon oxidative processes. Autoimmun. Rev. 7: 574-578.
8. Elluru, S.R. et al. 2008. Modulation of human dendritic cell maturation and function by natural IgG antibodies. Autoimmun. Rev. 7: 487-490.
9. Fiocco, U. et al. 2008. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abata-cept. Autoimmun. Rev. 8: 76-82.
10. Gebe, J.A. et al. 2008. Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice. J. Autoimmun. 30: 197-206.
11. Gonnella, P.A. et al. 2008. Inhibition of experimental autoimmune myocarditis: peripheral deletion of TcR Vbeta 8.1, 8.2+ CD4+ T cells in TLR-4 deficient mice. J. Autoimmun. 31: 180-187.
12. Gorelik, G. & B. Richardson. 2009. Aberrant T cell ERK pathway signaling and chromatin structure in lupus. Autoimmun. Rev. 8: 196-198.
13. Jenks, S.A. & I. Sanz. 2009. Altered B cell receptor signaling in human systemic lupus erythematosus. Autoimmun. Rev. 8: 209-213.
14. Katzav, A. et al. 2008. Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS-SLE (depression). J. Autoimmun. 31: 393-398.
15. Lorusso, L. et al. 2009. Immunological aspects of chronic fatigue syndrome. Autoimmun. Rev. 8: 287-291.
16. Neuhausen S.L. et al. 2008. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J. Autoimmun. 31: 160-165.
17. Stojanovich, L. & D. Marisavljevich. 2008. Stress as a trigger of autoimmune disease. Autoimmun. Rev. 7: 209-213.
18. Takaki, T. et al. 2008. Presence of donor-derived thymic epithelial cells in [B6-MRL/lpr] mice after allogeneic intra-bone marrow-bone marrow transplantation (IBM-BMT). J. Autoimmun. 31: 408-415.
19. Askenasy N., A. Kaminitz & S. Yarkoni. 2008. Mechanisms of T regulatory cell function. Autoimmun. Rev. 7: 370-375.
20. Wing, K. et al. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
21. Pesu, M. et al. 2008. T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature 455: 246-250.
22. Zhou, L. et al. 2008. TGF-β-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453: 236-240.
23. Bettelli, E. et al. 2008. Induction and effector functions of T(H)17 cells. Nature 453: 1051-1057.
24. Stromnes I.M. et al. 2008. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 14: 337-342.
25. Veldhoen, M. et al. 2008. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453: 106-109.
26. Hogan, T.V. et al. 2008. Extrathymic mechanisms of T cell tolerance: lessons from autoimmune gastritis. J. Autoimmun. 31: 268-273.
27. Gomez-Martin, D., M. Diaz-Zamudio & J. Alcocer-Varela. 2008. Ubiquitination system and autoimmu-nity: the bridge towards the modulation of the immune response. Autoimmun. Rev. 7: 284-290.
28. La Cava, A. 2008. Tregs are regulated by cytokines: implications for autoimmunity. Autoimmun. Rev. 8: 83-87.
29. Sanchez-Pernaute, O. et al. 2008. Epigenetic clues to rheumatoid arthritis. J. Autoimmun. 30: 12-20.
30. Dardalhon, V. et al. 2008. Role of Th1 and Th17 cells in organ-specific autoimmunity. J. Autoimmun. 31: 252-256.
31. Lan, R.Y. et al. 2009. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J. A u-toimmun. 32: 43-51.
32. Wang, J. et al. 2008. Interleukin-27 suppresses experimental autoimmune encephalomyelitis during bone marrow stromal cell treatment. J. Autoimmun. 30: 222-229.
33. McKay, F.C. et al. 2008. CD127 immunophenotyp-ing suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis. J. Autoimmun. 31: 52-58.
34. Reilly, C.M. et al. 2008. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice. J. Autoimmun. 31: 123-130.
35. Schwartz-Albiez, R. et al. 2008. Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy? Autoimmun. Rev. 7: 491-495.
36. Zigmond, E. et al. 2008. NKT lymphocyte polarization determined by microenvironment signaling: a role for CD8+ lymphocytes and beta- glycosphingolipids. J. Autoimmun. 31: 188-195.
37. Keenan, R.A. et al. 2008. Censoring of autoreactive B cell development by the pre-B cell receptor. Science 321: 696-699.
38. Cheng, H.M. & L. Chamley. 2008. Cryptic natural autoantibodies and co-potentiators. Autoimmun. Rev. 7: 431-434.
39. Czompoly, T. et al. 2008. Detailed analyses of antibodies recognizing mitochondrial antigens suggest similar or identical mechanism for production of natural antibodies and natural autoantibodies. Autoim-mun. Rev. 7: 463-467.
40. Poletaev A.B., V.L. Stepanyuk & M.E. Gershwin. 2008. Integrating immunity: the immunculus and self-reactivity. J. Autoimmun. 30: 68-73.
41. Seite, J.F. et al. 2008. What is the contents of the magic draft IVIg? Autoimmun. Rev. 7: 435-439.
42. Servettaz A. et al. 2008. Natural anti-endothelial cell antibodies. Autoimmun. Rev. 7: 426-430.
43. von Gunten, S. & H.U. Simon. 2008. Natural anti-Siglec autoantibodies mediate potential immunoreg-ulatory mechanisms: implications for the clinical use of intravenous immunoglobulins (IVIg). Autoimmun. Rev. 7: 453-456.
44. Binard, A. et al. 2008. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus? J. Autoimmun. 30: 63-67.
45. De Vita, S., L. Quartuccio & M. Fabris. 2008. Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both? Autoimmun. Rev. 8: 95-99.
46. Jara, L.J., G. Benitez & G. Medina. 2008. Prolactin, dendritic cells, and systemic lupus erythematosus. Au-toimmun. Rev. 7: 251-255.
47. Meyer-Bahlburg, A. & D.J. Rawlings. 2008. B cell autonomous TLR signaling and autoimmunity. Au-toimmun. Rev. 7: 313-316.
48. Puliaeva, I., R. Puliaev & C.S. Via. 2009. Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE. Autoimmun. Rev. 8: 219-223.